Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 14Gastrointestinal 13Genitourinary 11Other hematologic neoplasm 9Gynecologic 9Thoracic 6Head & Neck 6CNS 5Plasma cell 4Sarcoma 3Myeloid 3Tumor-Agnostic 2Lymphoid 2Dermatologic 2Other solid neoplasm 1Endocrine 1

Conditions

Neoplasms 2

Interventions

Paclitaxel 26Carboplatin 25pembrolizumab 22Gemcitabine 22Nivolumab 20Cisplatin 15Bevacizumab 14Docetaxel 13Pemetrexed 12Ipilimumab 12Erlotinib Hydrochloride 12Capecitabine 12Fluorouracil 11Irinotecan 10Afatinib 10eribulin 9BI 6727 9130-nm albumin-bound paclitaxel 9Radiotherapy 8Magnetic Resonance Spectroscopy 8Leucovorin 8Everolimus 8Cyclophosphamide 8Albumin-Bound Paclitaxel 8olaparib 7Oxaliplatin 7lenvatinib 6avelumab 6Trastuzumab 6Cetuximab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Standard of Care × Tumor-Agnostic × Clear all
NCT03244826 2024-08-16

Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation

Dana-Farber Cancer Institute

Phase NA Completed
404 enrolled 9 charts
Tumor-Agnostic

Neoplasms

NCT04000581 2022-07-22

Impact of Early Mobility on Post-Surgery Recovery in Patients Undergoing Oncologic Surgeries

Roswell Park Cancer Institute

Phase NA Terminated
17 enrolled 8 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡